报告人： Prof. Rachela Popovtzer, Bar-Ilan University
报告题目：Nanotheranostics for Personalized Medicine
报告时间： 2：00 PM, Dec 25th (Monday)
报告地点：909-B
Abstract
The development of biocompatible nanoparticlesfor molecular imaging and targeted therapy is an area of considerable currentinterest across a number of disciplines. Nanoparticles are expected to play amajor role in the future of medical theranostics due to their many advantagesover the conventional contrast agents and over small-molecular-weight drugs,such as prolonged blood circulation time, controlled biological clearancepathways and specific molecular targeting capabilities. In this presentation, wewill share our recent work with gold nanoparticles including early diagnosis ofdiseases, targeted drug delivery with fewer side effects, and novel therapeuticapproaches. In addition, the use of gold nanoparticles for in vivo celltracking and for stratified medicine will be presented.
Biography
Rachela Popovtzer is anAssociate Professor, Head of the Bioengineering Track and Head of theLaboratory of Nanomedicine in the Faculty of Engineering at Bar IlanUniversity, which she joined in 2008. She is a member of the Bar-Ilan Instituteof Nanotechnology and Advanced Materials (BINA). She was a Visiting Professorat Memorial Sloan Kettering Cancer Center during 2016. Prof. Popovtzer receivedher M.Sc. and PhD in Electrical Engineering from Tel Aviv University, and herB.Sc. in Physics from BIU. She was a postdoctoral fellow in the University ofMichigan with Prof. Raoul Kopelman. Prof. Popovtzer is a winner of numerousinternational grants and awards, such as the Intel Prize, NIH grant, the EUhorizon 2020 grant and the Atol Charitable Trust Fellow in Nano Medicine.
Contact:Prof. Zhuang Liu
责任编辑：杨娟
